Autori: Hadden Robert DM
Naslov | Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial (Article; Early Access) |
Autori | Hadden Robert DM Andersen Henning Bril Vera Basta Ivana Z Rejdak Konrad Duff Kim Greco Erin Hasan Shabbir Anderson Smits Colin Ay Hakan |
Info | JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, (2024), vol. br. , str. - |
Projekat | Takeda Development Center Americas, Inc.; Takeda Development Center Americas, Inc. - Takeda Pharmaceuticals International AG |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|